Article Text
Abstract
In terms of ethical implications, Boers, van Delden and Bredenoord (2018) have made an interesting step forward with their model of organoids as hybrids, which seeks to find a balance between subject-like value and object-like value. Their framework aims to introduce effective procedures not to exploit donors and to increase their engagement, but it does not seem to take sufficient account of how organoids are used and how donors and society as a whole may want to act about such uses. I will concentrate my remarks on three points that I consider relevant. The first comment concerns the so-called mini-brains. The second one is related to the issue of consent and long-term ‘control’ over the organic material granted by donors. The last comment focuses on ‘genetic minorities’.
- chimeras
- clinical trials
- donation/procurement of organs/tissues
- neuroethics
- stem cell research
Statistics from Altmetric.com
Footnotes
Contributors AZ is the sole author of the paper.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Animus: human-embodied animals
- Organoids as hybrids: ethical implications for the exchange of human tissues
- Cerebral organoids: ethical issues and consciousness assessment
- Lessons from Frankenstein 200 years on: brain organoids, chimaeras and other ‘monsters’
- Liver organoids: from basic research to therapeutic applications
- Organoids in gastrointestinal diseases: from experimental models to clinical translation
- The significance of induced pluripotent stem cells for basic research and clinical therapy
- Patient-derived cellular models of primary ciliopathies
- Research guidelines for embryoids
- Stem cell-derived embryo models: moral advance or moral obfuscation?